Cryptenamine Acetates
Generic Name: cryptenamine acetates
Manufactured by MEDPOINTE PHARM HLC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CRYPTENAMINE ACETATES (260CSR UNIT/ML). Application: NDA008814.
Overview
Manufactured by MEDPOINTE PHARM HLC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CRYPTENAMINE ACETATES (260CSR UNIT/ML). Application: NDA008814.
Dosage
Available as injectable for injection use.
Related Medications
Ratanhia, Aesculus Hippocastanum, Collinsonia Canadensis, Paeonia Officinalis, Negundo
ratanhia, aesculus hippocastanum, collinsonia canadensis, paeonia officinalis, negundo
Uses For the temporary relief of symptoms associated with hemorrhoids.
Luspatercept
luspatercept
Erythroid Maturation Agent [EPC]
11 DESCRIPTION Luspatercept-aamt is an erythroid maturation agent. Luspatercept-aamt is a receptor fusion protein consisting of a modified extracellular domain of the human activin receptor type IIB linked to a human IgG1 Fc domain with a calculated molecular mass of approximately 76 kD. Luspatercept is produced in Chinese hamster ovary cells by recombinant DNA technology.
Human Fibrinogen, Human Thrombin
human fibrinogen, human thrombin
Dosage form: KIT. Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.